August 21, 2017 6:51 PM ET

Pharmaceuticals

Company Overview of E. Merck KG

Key Executives for E. Merck KG

NameBoard RelationshipsTitleAge
Karl-Ludwig Kley 141 RelationshipsMember of executive Board66
Stefan Oschmann No RelationshipsChairman of the Executive Board of Merck KGaA and Chief Executive Officer at Merck KGaA 60

E. Merck KG Board Members*

NameBoard RelationshipsPrimary CompanyAge
Johannes Baillou 7 RelationshipsE. Merck KG52
Frank Stangenberg-Haverkamp 12 RelationshipsE. Merck KG69
Wolfgang Büchele Ph.D., Chemistry 37 RelationshipsM+W Group GmbH58
Albrecht Merck 18 RelationshipsMerck Kommanditgesellschaft auf Aktien67
Theo Siegert 67 RelationshipsDKSH Holding Ltd.70
View All Board Members

E. Merck KG Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Management Board Frank Stangenberg-Haverkamp12 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
422.2K
Bonus
425.9K
Total Short Term Compensation
598.9K
Total Value of Options
8.2M
Compensation as of Fiscal Year
E. Merck KG CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Member of Audit Committee
August 18, 2017 5:32 AM ET
Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Director
August 18, 2017 5:32 AM ET
Sunzen Biotech Berhad Appoints Ooi Bee Hoon as Independent and Non Executive Member of Nomination Committee
August 18, 2017 5:32 AM ET
Depomed, Inc. Announces Executive Appointments
August 17, 2017 8:28 PM ET
Merz Neuroscience Appoints Kevin O'Brien as Vice President and U.S. Head of Neuroscience Business
August 17, 2017 11:45 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact E. Merck KG, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.